ANTI-FACTOR Xa MEASUREMENTS IN CRITICALLY-ILL SURGICAL PATIENTS TO EXAMINE ENOXAPARIN METABOLISM AND OPTIMIZE ENOXAPARIN DOSE

被引：0
|
作者：
Wall, V [1 ]
Fleming, K. [1 ]
Pannucci, C. [1 ]
机构：
[1] Univ Utah, South Jordan, UT USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2017年 / 65卷 / 01期
关键词：
D O I：
10.1136/jim-2016-000365.151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
151
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [1] Anti-Factor Xa measurements in acute care surgery patients to examine enoxaparin dose
    Wall, Vanessa
    Fleming, Kory, I
    Tonna, Joseph E.
    Nunez, Jade
    Lonardo, Nick
    Shipley, R. Wayne
    Nirula, Ram
    Pannucci, Christopher J.
    [J]. AMERICAN JOURNAL OF SURGERY, 2018, 216 (02): : 222 - 229
  • [2] Anti-Factor Xa Activity of Prophylactic Enoxaparin Regimens in Critically Ill Patients
    Helviz, Yigal
    Dzigivker, Ilia
    Raveh-Brawer, David
    Hersch, Moshe
    Zevin, Shoshana
    Einav, Sharon
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (02): : 108 - 113
  • [3] Anti-factor XA levels in critically ill trauma patients treated for venous thromboembolism with enoxaparin.
    Sing, R
    Barrett, MC
    Huynh, T
    Miles, W
    Jacobs, D
    Thomason, M
    Rutherford, EJ
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A170 - A170
  • [4] Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients
    Vincent, Philippe D.
    Albert, Martin
    Champagne, Marie-Christine
    Zikos, Theodora
    Boulanger, Isabelle
    Blais, Lucie
    Williamson, David R.
    [J]. JOURNAL OF CRITICAL CARE, 2011, 26 (04) : 347 - 351
  • [5] Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
    David Oliver Hamilton
    Alexander Main-Ian
    Jessie Tebbutt
    Maya Thrasher
    Alicia Waite
    Ingeborg Welters
    [J]. Thrombosis Journal, 19
  • [6] Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
    Hamilton, David Oliver
    Main-Ian, Alexander
    Tebbutt, Jessie
    Thrasher, Maya
    Waite, Alicia
    Welters, Ingeborg
    [J]. THROMBOSIS JOURNAL, 2021, 19 (01)
  • [7] Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
    Dibiasi, Christoph
    Gratz, Johannes
    Wiegele, Marion
    Baierl, Andreas
    Schaden, Eva
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [8] ANTI-FACTOR XA LEVELS IN PICU PATIENTS ON ENOXAPARIN FOR VENOTHROMBOEMBOLISM PROPHYLAXIS
    Marshall, Amanda
    Malone, Matthew
    Yee, Addison
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [9] Optimal dose of enoxaparin in critically ill trauma and surgical patients
    Rutherford, EJ
    Schooler, WG
    Sredzienski, E
    Abrams, JE
    Skeete, DA
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 58 (06): : 1167 - 1170
  • [10] Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
    S Lage
    R Carvalho
    L Kopel
    M Ribeiro
    J Bastos
    A Fagundes Jr
    H Araujo
    C Strunz
    P Garbes-Netto
    [J]. Critical Care, 10 (Suppl 1):
12345